Spero Health

Spero Health

Spero Health runs outpatient drug and alcohol addiction treatment centers, primarily in Kentucky, Indiana, Ohio, Tennessee, West Virginia, and Virginia. Its services include medication-assisted treatment (MAT) with drugs like Suboxone and Vivitrol, individual and group counseling, and recovery support for employment and housing. The firm operates under ASAM treatment guidelines and recently added a Partial Hospitalization Program (PHP) paired with recovery housing in select areas. The firm deploys capital into brick-and-mortar clinics plus a telehealth platform that extends access to patients who cannot attend in person. Its integrated care model combines physician services, counseling, and recovery support. Spero Health accepts commercial insurance and Medicaid, making it accessible to a broad patient base. No named portfolio companies or co-investors are disclosed. Spero Health maintains no disclosed separate investment vehicles, foundations, or additional offices. Its operational model is centered on direct patient care through clinics and telehealth, with a recent expansion into higher-acuity PHP and sober living. In the last 24 months, it has continued to operate and grow its telehealth services across the six-state region, reflecting ongoing demand. The firm's structural differentiator is its focus on a single high-need healthcare vertical, addiction treatment, delivered through both physical and virtual channels. This contrasts with diversified healthcare platforms. Spero Health's willingness to accept Medicaid and its integration of counseling and support services create a relatively comprehensive care model in a fragmented market.